Leading the Way in Life Science Technologies

GEN Exclusives

More »
Insight & Intelligence™

Related to Sanofi-Aventis Bypasses Genzyme Board and Takes $18.5B Bid Directly to Shareholders

Be sure to take the GEN Poll

CRISPR Patent Controversy

Do you think recently released email from a former Broad Institute scientist to Jennifer Doudna will expedite a final legal decision on who owns the CRISPR patent?

More »